These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33252579)

  • 1. FOLLOW-UP ADHERENCE IN PATIENTS WITH NONPROLIFERATIVE DIABETIC RETINOPATHY PRESENTING TO AN OPHTHALMIC EMERGENCY DEPARTMENT.
    Watane A; Kalavar M; Vanner EA; Cavuoto K; Sridhar J
    Retina; 2021 Jun; 41(6):1293-1301. PubMed ID: 33252579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PATIENTS PRESENTING EMERGENTLY WITH PROLIFERATIVE DIABETIC RETINOPATHY: Follow-up and Factors Associated With Compliance.
    Hinkle JW; Flynn HW; Banta JT; Vanner EA
    Retina; 2020 May; 40(5):928-935. PubMed ID: 30897069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results after lens extraction in patients with diabetic retinopathy: early treatment diabetic retinopathy study report number 25.
    Chew EY; Benson WE; Remaley NA; Lindley AA; Burton TC; Csaky K; Williams GA; Ferris FL
    Arch Ophthalmol; 1999 Dec; 117(12):1600-6. PubMed ID: 10604663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid-Lowering Medications Are Associated with Lower Risk of Retinopathy and Ophthalmic Interventions among United States Patients with Diabetes.
    Vail D; Callaway NF; Ludwig CA; Saroj N; Moshfeghi DM
    Am J Ophthalmol; 2019 Nov; 207():378-384. PubMed ID: 31194953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients' Adherence to Recommended Follow-up Eye Care After Diabetic Retinopathy Screening in a Publicly Funded County Clinic and Factors Associated With Follow-up Eye Care Use.
    Keenum Z; McGwin G; Witherspoon CD; Haller JA; Clark ME; Owsley C
    JAMA Ophthalmol; 2016 Nov; 134(11):1221-1228. PubMed ID: 27632231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal Nonperfusion Characteristics on Ultra-Widefield Angiography in Eyes With Severe Nonproliferative Diabetic Retinopathy and Proliferative Diabetic Retinopathy.
    Nicholson L; Ramu J; Chan EW; Bainbridge JW; Hykin PG; Talks SJ; Sivaprasad S
    JAMA Ophthalmol; 2019 Jun; 137(6):626-631. PubMed ID: 30973596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Associated with Non-compliance for Diabetic Retinopathy Follow-up in an Urban Safety-Net Hospital.
    Chen AJ; Hwang V; Law PY; Stewart JM; Chao DL
    Ophthalmic Epidemiol; 2018; 25(5-6):443-450. PubMed ID: 30081686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to ophthalmology referral, treatment and follow-up after diabetic retinopathy screening in the primary care setting.
    Bresnick G; Cuadros JA; Khan M; Fleischmann S; Wolff G; Limon A; Chang J; Jiang L; Cuadros P; Pedersen ER
    BMJ Open Diabetes Res Care; 2020 Jun; 8(1):. PubMed ID: 32576560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous beading in two or more quadrants might not be a sensitive grading criterion for severe nonproliferative diabetic retinopathy.
    Chen L; Zhang X; Wen F
    Graefes Arch Clin Exp Ophthalmol; 2018 Jun; 256(6):1059-1065. PubMed ID: 29626228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vision-Related Functional Burden of Diabetic Retinopathy Across Severity Levels in the United States.
    Willis JR; Doan QV; Gleeson M; Haskova Z; Ramulu P; Morse L; Cantrell RA
    JAMA Ophthalmol; 2017 Sep; 135(9):926-932. PubMed ID: 28750122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18.
    Davis MD; Fisher MR; Gangnon RE; Barton F; Aiello LM; Chew EY; Ferris FL; Knatterud GL
    Invest Ophthalmol Vis Sci; 1998 Feb; 39(2):233-52. PubMed ID: 9477980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Factors Associated with Vision and Edema Outcomes.
    Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Melia M; Chen E; Pavlica MR; Jampol LM;
    Ophthalmology; 2018 Nov; 125(11):1776-1783. PubMed ID: 29980333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the DRCR Retina Network Approach to Management With Initial Observation for Eyes With Center-Involved Diabetic Macular Edema and Good Visual Acuity: A Secondary Analysis of a Randomized Clinical Trial.
    Glassman AR; Baker CW; Beaulieu WT; Bressler NM; Punjabi OS; Stockdale CR; Wykoff CC; Jampol LM; Sun JK;
    JAMA Ophthalmol; 2020 Apr; 138(4):341-349. PubMed ID: 32077907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RELATIONSHIP BETWEEN OBSTRUCTIVE SLEEP APNEA AND THE PRESENCE AND SEVERITY OF DIABETIC RETINOPATHY.
    Chang AC; Fox TP; Wang S; Wu AY
    Retina; 2018 Nov; 38(11):2197-2206. PubMed ID: 28937527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of eye disorders in diabetes (SPEED) in India. Report # 2. Diabetic retinopathy and risk factors for sight threatening diabetic retinopathy in people with type 2 diabetes in India.
    Rajalakshmi R; Behera UC; Bhattacharjee H; Das T; Gilbert C; Murthy GVS; Pant HB; Shukla R;
    Indian J Ophthalmol; 2020 Feb; 68(Suppl 1):S21-S26. PubMed ID: 31937724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First Incidence and Progression Study for Diabetic Retinopathy in Portugal, the RETINODIAB Study: Evaluation of the Screening Program for Lisbon Region.
    Dutra Medeiros M; Mesquita E; Gardete-Correia L; Moita J; Genro V; Papoila AL; Amaral-Turkman A; Raposo JF
    Ophthalmology; 2015 Dec; 122(12):2473-81. PubMed ID: 26383994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment compliance and adherence among patients with diabetic retinopathy and age-related macular degeneration treated by anti-vascular endothelial growth factor under universal health coverage.
    Angermann R; Rauchegger T; Nowosielski Y; Casazza M; Bilgeri A; Ulmer H; Zehetner C
    Graefes Arch Clin Exp Ophthalmol; 2019 Oct; 257(10):2119-2125. PubMed ID: 31286206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study.
    Chew EY; Ferris FL; Csaky KG; Murphy RP; Agrón E; Thompson DJ; Reed GF; Schachat AP
    Ophthalmology; 2003 Sep; 110(9):1683-9. PubMed ID: 13129862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Diabetes-Related Eye Complications and Symptoms of Anxiety and Depression.
    Rees G; Xie J; Fenwick EK; Sturrock BA; Finger R; Rogers SL; Lim L; Lamoureux EL
    JAMA Ophthalmol; 2016 Sep; 134(9):1007-14. PubMed ID: 27387297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical Trial.
    Brown DM; Wykoff CC; Boyer D; Heier JS; Clark WL; Emanuelli A; Higgins PM; Singer M; Weinreich DM; Yancopoulos GD; Berliner AJ; Chu K; Reed K; Cheng Y; Vitti R
    JAMA Ophthalmol; 2021 Sep; 139(9):946-955. PubMed ID: 34351414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.